Email Survey Audience Analysis Study (CTP)

OMB#: 0910-0697 | Exp. 12/31/2023

Appendix D. 2021 FDA CTP Email Survey Audience Analysis Study:

Informed Consent (Short Version of the Survey)

Welcome to the 2021 FDA Center for Tobacco Products (CTP) Email Survey!

You must be 18 years of age or older to be eligible to complete this survey.

The purpose of this 2021 FDA CTP Email Survey is to see how satisfied you are with CTP’s e-newsletters (i.e., CTP Connect, CTP News, and Spotlight on Science), and for us to learn a little bit about you.

This 5-minute anonymous survey is completely voluntary, and you may quit, without penalty, at any time. We anticipate up to 665 individuals will respond to this survey. Your data will be reported in the aggregate. Individual respondents’ names, email addresses, IP addresses, and other personal identifying information will not be collected. If you feel uncomfortable answering any questions, you may choose the “prefer not to answer” response option. While there are no direct benefits to your participation in this survey, your feedback will help us improve our email communications.

If you have any questions about this survey, or any problems completing the survey, please contact Dr. Everly Macario at IQ Solutions, Inc., at 224-244-3965.

If you click on “Start survey now,” you voluntarily agree to take part in this survey. Click one of the options below.

I have read, understand, and had time to consider all the information above. My questions have been answered and I have no further questions.

_____ Start survey now / I voluntarily agree to participate in this study.
[BEGIN SURVEY]

I have read, understand, and had time to consider all the information above. My questions have been answered and I have no further questions.

_____ Exit survey / I do not want to participate in this study. [TERMINATE SURVEY; GO TO TERMINATION TEXT 3]

[TERMINATION TEXT 3:] You have indicated that you do not want to participate in the 2021 CTP Email Survey and will now exit the survey. If you decide later that you would like to participate, you can use the same email invitation to access the survey. Thank you for your time!

Paperwork Reduction Act Statement: The public reporting burden for this information collection has been estimated to average 1 minute per response to review this informed consent form (the time estimated to read, review, and complete). Send comments regarding this burden estimate or any other aspects of this information collection, including suggestions for reducing burden, to PRAStaff@fda.hhs.gov.

2021 FDA CTP Email Survey Audience Analysis Study: 

Informed Consent (Long Version of the Survey)

 

 

Welcome to the 2021 FDA Center for Tobacco Products (CTP) Email Survey! 

 

You must be 18 years of age or older to be eligible to complete this survey. 

 

The purpose of this 2021 FDA CTP Email Survey is to see how satisfied you are with CTP’s e-newsletters (i.e., CTP Connect, CTP News, and Spotlight on Science), and for us to learn a little bit about you.  

 

This 8-minute anonymous survey is completely voluntary, and you may quit, without penalty, at any time. We anticipate up to 664 individuals will respond to this survey. Your data will be reported in the aggregate. Individual respondents’ names, email addresses, IP addresses, and other personal identifying information will not be collected. If you feel uncomfortable answering any questions, you may choose the “prefer not to answer” response option. While there are no direct benefits to your participation in this survey, your feedback will help us improve our email communications.   

 

If you have any questions about this survey, or any problems completing the survey, please contact Dr. Everly Macario at IQ Solutions, Inc., at 224-244-3965.   

 

If you click on “Start survey now,” you voluntarily agree to take part in this survey. Click one of the options below. 

 

I have read, understand, and had time to consider all the information above. My questions have been answered and I have no further questions. 

_____ Start survey now / I voluntarily agree to participate in this study.  
[BEGIN SURVEY] 

 

I have read, understand, and had time to consider all the information above. My questions have been answered and I have no further questions. 

_____ Exit survey / I do not want to participate in this study. [TERMINATE SURVEY; GO TO TERMINATION TEXT 3] 

 

[TERMINATION TEXT 3:] You have indicated that you do not want to participate in the 2021 CTP Email Survey and will now exit the survey. If you decide later that you would like to participate, you can use the same email invitation to access the survey. Thank you for your time!  

 

Paperwork Reduction Act Statement: The public reporting burden for this information collection has been estimated to average 1 minute per response to review this informed consent form (the time estimated to read, review, and complete). Send comments regarding this burden estimate or any other aspects of this information collection, including suggestions for reducing burden, to PRAStaff@fda.hhs.gov.